| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp | EVP of R&D & CTO | Common Stock | 13,419 | $367,814 | $27.41 | 29 Jan 2026 | Direct |
| QuidelOrtho Corp | EVP of R&D & CTO | Restricted Stock Units | 36,152 | $304,261 | $41.42 | 30 Jan 2026 | Direct |
| QuidelOrtho Corp | EVP of R&D & CTO | Non-Qualified Stock Options | 36,150 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QDEL | QuidelOrtho Corp | 30 Jan 2026 | 2 | $0 | 4 | EVP of R&D & CTO | 03 Feb 2026, 19:50 |
| QDEL | QuidelOrtho Corp | 29 Jan 2026 | 3 | -$27,657 | 4 | EVP of R&D & CTO | 02 Feb 2026, 19:07 |
| QDEL | QuidelOrtho Corp | 15 Oct 2025 | 3 | -$182,322 | 4 | EVP of R&D & CTO | 17 Oct 2025, 16:16 |
| QDEL | QuidelOrtho Corp | 29 Jan 2025 | 2 | $0 | 4 | EVP of R&D & CTO | 31 Jan 2025, 18:29 |
| QDEL | QuidelOrtho Corp | 07 Oct 2024 | 0 | $0 | 3 | EVP of R&D & CTO | 17 Oct 2024, 16:47 |